| Name | HEMADO,2-(1-Hexynyl)-N-methyladenosine |
|---|---|
| Synonyms | 2-(1-Hexynyl)-N6-methyladenosine |
| Description | HEMADO is a potent and selective adenosine A3 receptor agonist with a Ki of 1.1 nM at the human A3 subtype[1]. |
|---|---|
| Related Catalog | |
| Target |
Ki: 1.1 nM (human A3 subtype)[1] |
| In Vitro | HEMADO (compound 8a) has Kis of 327 nM and 1230 nM for A1 and A2A and a EC50 of 100 μM for A2B receptors[2]. |
| References |
| Density | 1.46g/cm3 |
|---|---|
| Boiling Point | 696.8ºC at 760 mmHg |
| Molecular Formula | C17H23N5O4 |
| Molecular Weight | 361.39600 |
| Flash Point | 375.2ºC |
| Exact Mass | 361.17500 |
| PSA | 125.55000 |
| LogP | 0.09420 |
| Index of Refraction | 1.677 |